Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

FranceBack to France

Clinical trials in Dreux

2 clinical trials in Dreux, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Dreux at a glance
2
clinical trials
  • Recruiting now0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Dreux

Open in trial search

Cardiac failure

Not yet recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Acetazolamide
  • Sponsor:Centre Hospitalier Universitaire De Montpellier

Tracheobronchitis bacterial

Not yet recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amikacin
  • Sponsor:Centre Hospitalier Regional Universitaire De Tours

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Dreux

What the registry says about research in the country

01 Dreux
Bacterial Infections and Mycoses
In Dreux, investigators are evaluating innovative antimicrobial strategies for severe pulmonary infections. The trial examines inhaled amikacin as a brief, targeted therapy aimed at reducing bacterial load in intensive care patients. Evaluation of aerosolized antibiotics in intensive care settings Comparison with placebo for infection control Assessment of safety profile for inhaled antimicrobials Impact on ventilator‑associated pneumonia rates Both studies are actively recruiting at a single site in Dreux, with two investigators leading the effort.
Cardiovascular Diseases
Heart failure research in Dreux aims to enhance fluid management and quality of life for out‑patients. The protocol adds acetazolamide to standard diuretic therapy and incorporates remote monitoring to track patient response. Adjunct diuretic strategies for ambulatory heart failure Weight reduction and symptom relief assessment Integration of remote monitoring technologies Evaluation of left ventricular ejection fraction subgroups The trial is recruiting participants across the city’s sole research centre, reflecting a focused commitment to cardiovascular innovation.
Respiratory Tract Diseases
The respiratory portfolio in Dreux concentrates on preventing complications of critical illness. Researchers target ventilator‑associated tracheobronchitis to stop its progression toward more severe pneumonia. Prevention of progression to ventilator‑associated pneumonia Short‑duration antibiotic regimens in ICU patients Clinical outcomes assessed at Day 28 Multicentre double‑blind randomized design With two active recruiting studies, the city’s single site remains a hub for advancing respiratory care in Europe.
Back to FranceAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.